• Return to Headlines

Nektar Therapeut Up 23.1% Since SmarTrend Uptrend Call (NKTR)

By Shiri Gupta

SmarTrend identified an Uptrend for Nektar Therapeut (NASDAQ:NKTR) on February 15th, 2018 at $83.72. In approximately 4 weeks, Nektar Therapeut has returned 23.11% as of today's recent price of $103.07.

Nektar Therapeut share prices have moved between a 52-week high of $111.36 and a 52-week low of $11.41 and are now trading 803% above that low price at $103.07 per share. The 200-day and 50-day moving averages have moved 0.35% higher and 2.07% higher over the past week, respectively.

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral, and immunology.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Nektar Therapeut shares.

Log in and add Nektar Therapeut (NKTR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights nektar therapeut

Ticker(s): NKTR